Interactions of phospholipid vesicles with murine lymphocytes. II. Correlation between altered surface properties and enhanced proliferative response.
The effect of unilamellar lipid vesicles composed of dioleoyl lecithin (DOL), egg yolk lecithin (EYL), 1:1 EYL:cholesterol (Chol), dipalmitoyl lecithin (DPL), and dimyristoyl lecithin (DML) on the mitogenic response in mouse lymphocytes was tested. Cortisone-resistant thymocytes were briefly treated with lipid vesicles and subsequently stimulated with concanavalin A (con A). All of the lipid vesicles induced an enhanced mitogenic response on day 3 as tested by [3H]TdR incorporation and by counting total cells. The order of enchanced [3H]TdR incorporation (less than or equal to 5.3 times the control) was DML greater than DPL greater than 1:1 EYL:Chol greater than EYL congruent to DOL greater than untreated control cells. These increases were paralleled by increased numbers of total cells. The response of spleen cells to a B-cell mitogen, bacterial lipopolysaccharide, was similarly enhanced by vesicle pretreatments in the same order. Vesicle treatments alone were not mitogenic Pretreatment of cells with lipid vesicles modified lectin binding: DML and DPL increased the binding of [125I]con A by three to four times the control, whereas 1:1 EYL:Chol, EYL, or DOL had little or no effect. The binding of [125I]phytohemagglutinin-P (PHA-P) to vesicle-treated cells was indistinguishable from untreated cells. The lectin (con A; PHA-P)-induced agglutination of vesicle-treated cells was also modified by different lipid vesicles in the same order as the mitogenic response. Based on the results presented in the accompanying report [6], we find that the cell surface adsorption properties of the applied lipid vesicles correlate with their ability to enhance the mitogenic response, and that they modify agglutinability and lectin binding. These results are further discussed in terms of the possible alteration of membrane properties and subsequent cellular activity.
D000818:Animals; D002455:Cell Division; D003208:Concanavalin A; D003348:Cortisone / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D008297:Male; D008567:Membranes, Artificial; D051379:Mice; D010713:Phosphatidylcholines / Q000378:metabolism*; D013601:T-Lymphocytes / Q000187:drug effects / Q000502:physiology*; D013950:Thymus Gland / Q000187:drug effects / Q000502:physiology
D008567:Membranes, Artificial; D010713:Phosphatidylcholines; D003208:Concanavalin A; D004247:DNA; D003348:Cortisone